INFORMATION:
In preclinical models, antiviral better inhibits COVID-19 than Remdesivir; further studies warranted
2021-01-25
(Press-News.org) Working in preclinical models, researchers report that plitidepsin, a drug with limited clinical approval for the treatment of multiple myeloma, is more potent against SARS-CoV-2 than remdesivir, an antiviral that received FDA emergency use authorization for the treatment of COVID-19 in 2020. The results suggest plitidepsin should be further evaluated as a COVID-19 therapy, the authors say; because it targets a host protein rather than a viral protein, if treatment proves successful in humans, the SARS-CoV-2 virus won't be easily able to gain resistance against the drug through mutation. The ongoing SARS-CoV-2 pandemic has created the need for antiviral therapeutics that can be swiftly moved into the clinic. This has led researchers to screen clinically approved antivirals. While traditional antivirals, like remdesivir, target viral enzymes that are often subject to mutation, and thus to the development of drug resistance, antivirals that target the cell host proteins required for viral replication could avoid resistance. In earlier work investigating host proteins likely to play a role in the viral life cycle of SARS-CoV-2, including a study in Science in October 2020, Kris White and colleagues found that targeting the host translation machinery that is used in the replication of many viral pathogens could greatly inhibit SARS-CoV-2. Based on this they evaluated plitidepsin, a known inhibitor of a protein involved in host protein translation. In addition to having a limited clinical approval for treating multiple myeloma, it has also successfully completed a phase I/II clinical study for the treatment of COVID-19. Here, in studies in human cells, plitidepsin demonstrated potent anti-SARS-CoV-2 activity - 27.5-fold more so than remdesivir as tested in the same cell line. In a model of human lung cells, plitidepsin greatly reduced viral replication. After further experiments involving remdesivir and plitidepsin in vitro, the researchers suggest that plitidepsin has an additive effect with this approved drug and would be a potential candidate for a combined therapy. The researchers also tested the drug in mice later infected with SARS-CoV-2. Mice who received the drug prophylactically had reduced viral load and lung inflammation compared to control mice. "We believe that our data and the initial positive results from PharmaMar's clinical trial suggests that plitidepsin should be strongly considered for expanded clinical trials for the treatment of COVID-19," conclude the authors.
ELSE PRESS RELEASES FROM THIS DATE:
Mapping mutations that escape antibodies against COVID-19 suggests prior mapping incomplete
2021-01-25
A new approach to mapping viral mutations that "escape" leading clinical antibodies has revealed mutations in the SARS-CoV-2 virus that allow it to evade treatments, including a single amino-acid mutation that fully escapes Regeneron's antibody cocktail. These maps, say the authors, demonstrate that prior characterization of escape mutations was incomplete. They will also help to enable immediate interpretation of the effects of the mutations cataloged by viral genomic surveillance, say the authors. Several antibodies are in use or under development as therapies to treat COVID-19. As new SARS-CoV-2 variants emerge, it ...
Researchers engineer antibody that acts against multiple SARS-like viruses
2021-01-25
Researchers have engineered an antibody that neutralizes SARS-CoV-2 with a potency that "rivals" current lead SARS-CoV-2 clinical neutralizing antibodies, and that also broadly neutralizes a range of clade 1 sarbecoviruses. Their antibody, ADG-2, studied in mice, represents a "promising candidate" for the prevention and treatment of not only COVID-19, they say, but also of future respiratory diseases caused by SARS-related coronaviruses. Although two vaccines and two monoclonal antibody (mAb) therapies have been authorized for emergency use by the FDA, it is unknown whether these vaccines and treatments will provide broad protection against new emerging SARS-CoV-2 strains that originate in humans or animal reservoirs; this is partly ...
Nearly one in four families hesitant to take their child to ER during COVID-19 pandemic
2021-01-25
During the first wave of the COVID-19 pandemic, nearly one in four families responded that they would be unlikely to bring their child to the Emergency Department if they had an emergency condition, according to a survey from Ann & Robert H. Lurie Children's Hospital of Chicago published in the journal Academic Emergency Medicine. Greater hesitancy to seek emergency care was found in families living in under-resourced communities, those who rely on public insurance and in families who are Black, Latinx or Asian.
"We observed greater hesitancy to use the Emergency Department among more vulnerable demographic groups who historically showed high utilization of emergency care for their children," ...
Bioorthogonally catalyzed lethality strategy generates targeting drugs within tumor
2021-01-25
Cancer is the second leading cause of death in the world. The number of deaths and incidences is increasing each year. The metal-based anticancer drugs were used clinically worldwide, but suffer from poor selectivity, serious side effects and drug resistance. Tumor-targeting drug development is the basis for precise cancer treatment.
Recently, Professor Hongke Liu of Nanjing Normal University, Professor Jing Zhao and Academician Zijian Guo of Nanjing University have made breakthrough achievements in anticancer drug development. They proposed a "bio-orthogonally catalyzed lethality" (BCL) strategy ...
3-D printed Biomesh minimizes hernia repair complications
2021-01-25
Hernias are one of the most common soft tissue injuries. Hernias form when intra-abdominal content, such as a loop of the intestine, squeezes through weak, defective or injured areas of the abdominal wall.
The condition may develop serious complications, therefore hernia repair may be recommended. Repair consists of surgically implanting a prosthetic mesh to support and reinforce the damaged abdominal wall and facilitate the healing process. However, currently used mesh implants are associated with potentially adverse postsurgical complications.
"Although hernia mesh implants are mechanically strong and support abdominal tissue, making the patient feel comfortable initially, ...
CHEOPS finds unique planetary system
2021-01-25
Musical notes that sound pleasant together can form a harmony. These notes are usually in a special relationship with each other: when expressed as frequencies, their ratios result in simple fractions, such as four-thirds or three-halves. Similarly, a planetary system can also form a kind of harmony when planets, whose orbital period ratios form simple fractions, regularly attract each other with their gravity. When one planet takes three days to orbit its star and its neighbor takes two days, for example. Using the CHEOPS space telescope, scientists, led by astrophysicist Adrien Leleu of the Center for Space and Habitability of the University of Bern, the University of Geneva and ...
What's in a name? A new class of superconductors
2021-01-25
HOUSTON - (Jan. 25, 2021) - A new theory that could explain how unconventional superconductivity arises in a diverse set of compounds might never have happened if physicists Qimiao Si and Emilian Nica had chosen a different name for their 2017 model of orbital-selective superconductivity.
In a study published this month in npj Quantum Materials, Si of Rice University and Nica of Arizona State University argue that unconventional superconductivity in some iron-based and heavy-fermion materials arises from a general phenomenon called "multiorbital singlet pairing."
In superconductors, electrons form pairs and flow without resistance. Physicists cannot fully explain how ...
Climate change increases coastal blue carbon sequestration
2021-01-25
Coastal Blue Carbon (BC), which includes mangrove and saltmarsh tidal wetlands, of which was first coined a decade ago to describe the disproportionately large contribution of coastal vegetated ecosystems to global carbon sequestration. The role of BC in climate change mitigation and adaptation has now reached international prominence. Recent studies have reported BC's unique role in mitigating climate change, projected coastal wetlands area change, carbon stocks in response to historical sea level rise fluctuations, and the future roadmap relative to carbon sequestration studies. However, several questions remain unanswered:
Q1. What is the global extent and spatial distribution ...
Photocatalytic reaction in the shadow
2021-01-25
Solar-driven photoelectrochemical (PEC) water splitting is an attractive approach to convert solar energy into chemical energy. Among many photoelectrode materials, crystalline silicon (c-Si) has drawn considerable attention because of its earth abundance, narrow bandgap, and suitable band edge position for hydrogen evolution reaction (HER). However, c-Si suffers from low photovoltage generated from the solid-liquid junction.
Various strategies, such as the construction of p-n homojunctions, metal-insulator-semiconductor (MIS) junctions and p-n heterojunctions, have been adopted to obtain high photovoltage. The MIS junctions have been the focus of attention in PEC water splitting due to their simple fabrication and the potential to achieve higher efficiencies than p-n ...
The public health employment picture: Are graduates meeting the demands of the workforce?
2021-01-25
January 25, 2021 -- In a study to gain understanding of the future public health workforce, researchers at Columbia University Mailman School of Public Health and the Association of Schools and Programs of Public Health (ASPPH), conducted a large-scale analysis of the first employment outcomes of public health graduates and found that 78 percent were employed including 5 percent employed in fellowships and internships. Fifteen percent were continuing their studies; only 5 percent were not employed and job seeking. These indicators may ultimately expand public health's reach and lead to healthier communities overall. The study is the first national analysis of employment outcomes of public health graduates, and one of the only such analyses ...